Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.3650 (13.67%) ($4.8200 - $5.4500) on Mon. Sep. 14, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.61% (three month average) | RSI | 50 | Latest Price | $5.3650(13.67%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 2.6% a day on average for past five trading days. | Weekly Trend | CAPR declines -6.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) BWX(43%) LQD(39%) MCHI(18%) ONLN(18%) IBUY(17%) | Factors Impacting CAPR price | CAPR will decline at least -4.305% in a week (0% probabilities). TBT(-38%) USO(-37%) DRIV(-17%) REMX(-13%) XLC(-12%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -4.305% (StdDev 8.61%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-16.4(-405.68%) | Inflection Point | Yes | Resistance Level | $5.43 | 5 Day Moving Average | $4.76(12.71%) | 10 Day Moving Average | $5.07(5.82%) | 20 Day Moving Average | $5.43(-1.2%) | To recent high | -45.3% | To recent low | 5.3% | Market Cap | $106m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |